“…Intensitymodulated radiotherapy (IMRT), imageguided radiotherapy (IGRT), and stereotactic body radiotherapy (SBRT) facilitate optimization of dose to target, lung, breasts and heart in radiotherapy for mediastinal Hodgkin lymphoma, lung cancer or breast cancer [6,7,8,9,10]. Expanding on previous reports on dose calculation accuracy of various algorithms [11,12,13,14,15,16,17,18,19,20,21,22], dose calculation with advanced algorithms had been evaluated for different lung tumor geometries for 3D-conformal radiotherapy (3D-CRT) [23,24,25]. Concern had, however, been raised regarding the effects of dose calculation uncertainties of algorithms implemented in commercial IMRT treatment planning systems (TPS) [14,26,27].…”